undefined undefined
NaN.000
NaN.00%
NovaBay Pharmaceuticals (NYSE:NBY) received NYSE notice stating that the company is below compliance with listing standards pursuant to stockholders equity. The company must submit a plan by May 18, 2...
04-22 13:43
12月31日,Novabay Pharmaceuticals, Inc.(NBY.US)公布财报,公告显示公司2023财年净利润为-9.64百万美元,同比增加...
03-27 22:10
NovaBay press release (NYSE:NBY): Q4 GAAP EPS of -$1.33. Revenue of $3.7M (+2.8% Y/Y). More on NovaBay Seeking Alpha’s Quant Rating on NovaBay Historical earnings data for NovaBay Financial informatio...
03-27 05:03
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.
03-26 16:47
Revenues increased 7% compared to quarter from prior year and 15% from prior qu...
02-09 05:10
A substantial 24% of all online sales were from subscribers in 2023, up from approximately 14% in 2022. In addition, of the more than 13,000 customer reviews across all online channels, Avenova Spray averaged a 4.5-star
01-30 22:30
NovaBay Pharmaceuticals (AMEX:NBY) reported its Q3 earnings results on Thursday...
2023-11-10 05:35
NovaBay Pharmaceuticals (AMEX:NBY) is set to give its latest quarterly earnings...
2023-11-09 01:01
NovaBay Pharmaceuticals Announces Commercial Launch Of Avenova Allograft
2023-09-14 20:03
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 80 points on Monday. The Dow traded up 0.40% to 34,715.88 while the NASDAQ rose 0.58% to 13,841.50. The S&P 500, also rose, gaining, 0.52% to 4,480.87.
2023-09-12 00:03